logo
Select company
Select metric
$ 4.54MNet Cash Flow - Financing
VS
Market
39
Sector
54
Industry
63
History
60
$ 0.62Close
$ 0.36 - $ 4.96 52-Week Range
Ticker Information

Ticker

IBO

Company Name

IMPACT BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

IMPACT BIOMEDICAL INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBO - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 4.54M
3/31/2025$ 5.2M
12/31/2024$ 5.92M
9/30/2024$ 5.56M
6/30/2024$ 2.48M
12/31/2023$ 2.87M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) CF - Financing stands at $ 2.87M.
  • Over the past 5 years, IMPACT BIOMEDICAL INC's average CF - Financing has been $ 4.43M.
  • The median CF - Financing for IMPACT BIOMEDICAL INC during this period was $ 4.87M
  • IMPACT BIOMEDICAL INC reached its highest CF - Financing over the past 5 years at $ 5.92M.
  • The lowest CF - Financing recorded by IMPACT BIOMEDICAL INC in the same timeframe $ 2.48M

IMPACT BIOMEDICAL INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ 4.96MTCRT : ALAUNOS THERAPEUTICS INC $ 0ADTX : ADITXT INC $ 29.27MHSCS : HEARTSCIENCES INC $ 5.83MPMCB : PHARMACYTE BIOTECH INC $ -14.86MAPVO : APTEVO THERAPEUTICS INC $ 25.99MPALI : PALISADE BIO INC $ 3.73MACXP : ACURX PHARMACEUTICALS INC $ 7.87MGNPX : GENPREX INC $ 12.97MTTNP : TITAN PHARMACEUTICALS INC $ 1.46M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

IBO - Net Cash Flow - Financing, Last 5 years

$ 2.48M

Minimum

Jun 30, 2024

$ 5.92M

Maximum

Dec 31, 2024

$ 4.43M

Average

$ 4.87M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M